China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed, Find details about China Dtap from Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed
Indications
The product can induce immune response in recipients following immunization.
It is used to prevent diphtheria, tetanus and pertussis.
Highlights
1. Similar to Sanofi's Tripacel
2. Acellular pertussis is more safer, less adverse reactions than DTwP
3. Complete phase I, III Clinical Trial in China
4. Being registered in India
Dosage form
Freeze-dried powder for Injection
Specification
0.5 ml/vial/dose
Route of Administration
Intramuscular injection
Shelf life
24 Months